Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
Nature Medicine|November 9, 2019
Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapyDiego Chowell, Chirag Krishna, Federica Pierini, et al.Journal of Experimental & Clinical Cancer Research : CR|October 14, 2025
Deciphering the cellular tumor microenvironment landscape in salivary gland carcinomas using multiplexed imaging mass cytometryMarcel Mayer, Lisa Nachtsheim, Louis Jansen, et al.Urologic Oncology|November 13, 2024
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitorsSari Khaleel, Marlon Perera, Nathan Papa, et al.Nature Metabolism|June 19, 2023
A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariationElisa Benedetti, Eric Minwei Liu, Cerise Tang, et al.Cancer Research|December 15, 2020
Identifying Clear Cell Renal Cell Carcinoma Coexpression Networks Associated with Opioid Signaling and SurvivalJoseph R Scarpa, Renzo G DiNatale, Roy Mano, et al.The Lancet. Oncology|November 13, 2018
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort studyMartin H Voss, Albert Reising, Yuan Cheng, et al.Journal for Immunotherapy of Cancer|May 30, 2019
Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.Science Translational Medicine|September 15, 2021
Ectopic activation of the miR-200c-EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapyMinggang Zhang, Zeguo Zhao, Yuri Pritykin, et al.Journal for Immunotherapy of Cancer|October 24, 2019
Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinomaPooja Ghatalia, Jennifer Gordetsky, Fengshen Kuo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic CarcinomaAntoine Desilets, Joris L Vos, Nora Katabi, et al.Pageof 7